Earnings call transcript: Bio-Rad tops Q2 2026 estimates, shares fall after hours
What it means
- What to watch: Risk signal in Earnings — consider position sizing and correlated exposure.
- How the stock is trading: $BIO +1.77% in the latest session.
- Timing: It landed after the close, so the session change beside it was final before the story existed. The next session is the first that could react.
Where the stock stands
$BIO last traded at $369.95, +1.77% on the session. That is 6.6% below its 52-week high of $396.23 and 56% above its low of $236.73 — in the upper part of the range. The year's range spans 67% from low to high: a wide band — moves of several percent in a week are ordinary at that volatility. These are latest-session quotes, not live prices.
The bigger picture
Earnings stories turn less on the headline numbers than on how they compare with what analysts expected and on guidance for the next quarter; a beat with weak guidance can land worse than a miss with a raised outlook. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it reads.
Coming up
$BIO earnings in 11 days. These were scheduled before this story and are not caused by it, but the nearest is close enough that the next hard numbers on this company will arrive soon.
What to watch next
The $BIO page has the full chart, the filings and the valuation model behind these figures. Comparing how two or three outlets frame the same story is the quickest way to separate the facts from the angle. Wook AI, above, can pull live figures and do the math — how far $BIO is from its high, or how this week's coverage compares — on request.
How this analysis was made
Investing.com published it, and Wook filed it under Earnings. It reads bearish at medium severity because of “fall” in the wording, with nothing on the bullish side to offset it. It was matched to $BIO. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on August 4, 2026. $BIO has moved +6.35% ($347.86 to $369.95). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.